LILLE, France , June 12, 2024 /PRNewswire/ — Lesaffre, an independent key global player in fermentation and microorganisms, announces today the signing of a transaction with dsm-firmenich, a leading innovator in nutrition, health and beauty, regarding its yeast extract business. Lesaffre and dsm-firmenich have reached agreement for a multi-part collaboration in yeast derivatives serving the savory ingredients space. Lesaffre will acquire dsm firmenich’s yeast extract go-to-market organization and know-how, enabling production of dsm-firmenich’s yeast extract products in Lesaffre’s global manufacturing network.
This acquisition of talent and know-how and a technology partnership with dsm-firmenich will strengthen Lesaffre’s trajectory in the savory ingredients market, bolstering its current R&D expertise and expanding its range of high-quality products. Acquiring dsm-firmenich’s yeast extract processing technologies will enable Lesaffre to better serve customers in savory and other fermentation-based applications. It is a transformative strategic step for Biospringer by Lesaffre, a global provider of innovative natural origin solutions from yeast fermentation.
Biospringer will offer to its customers a wider range of products and solutions to improve taste, texture, and other desired properties in their various food applications. For Brice-Audren Riché, CEO of Lesaffre , “This transaction completely fits in our strategy to become a true global specialist in yeas.
